A consensus development approach to define national research priorities in bone metastases: Proceedings from NCIC CTG workshop

Clinical Oncology

Volumn 15, Issue 8, 2003, Pages 496-499

  Wu, Jackson ^a   Bezjak, A ^b   Chow, E ^b   Cross, P ^c   Genest, P ^c   Grant, N ^d   Kirkbride, P ^e   Roy, I ^f   Whelan, T ^g   Fitzgibbon, E ^c   Wong, R ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c OTTAWA REGIONAL CANCER CENTRE   (Canada)

^d SAINT JOHN REGIONAL HOSPITAL   (Canada)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

^f CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^g MCMASTER UNIVERSITY   (Canada)

Author keywords

Bone metastases; Clinical trials; Palliative radiotherapy

Indexed keywords

ARTICLE; BONE METASTASIS; BRAIN METASTASIS; CANADA; CANCER CENTER; CANCER RESEARCH; CLINICAL PROTOCOL; CLINICAL STUDY; CONTROLLED STUDY; FATIGUE; HEALTH SURVEY; HUMAN; MEDICAL SOCIETY; MEDICAL SPECIALIST; MUCOSA INFLAMMATION; MULTICENTER STUDY; PALLIATIVE THERAPY; PATIENT REFERRAL; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE FRACTIONATION; RADIATION INJURY; SYMPTOM; WORKSHOP;

EID: 10744221247     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2003.07.004     Document Type: Article

References (18)

1. Vella K, Goldfrad C, Rowan K, et al. Use of consensus development to establish national research priorities in critical care. BMJ 2000;320:976-980.
2. Neugebauer EA. Development of a consensus-assisted protocol: a new approach to improve study design (suppl). Eur J Surg 1999; 584:7-11.
3. Van der Beek AJ, Frings-Dresen MH, van Dijk FJ, et al. Priorities in occupational health research: a Delphi study in the Netherlands. Occup Environ Med 1997;54:504-510.
4. Schmidt K, Montgomery L, Bruene D, et al. Determining research priorities in pediatric nursing: a Delphi study. J Pediatr Nurs 1997; 12:201-207.
5. Wu J, Wong R, Johnston M, et al. Meta-analysis of dose-fractionation radiotherapy trials for the palliation of painful bone metastases. Int J Radiat Oncol Biol Phys 2003;55:594-605.
6. Wu JS, Bezjak A, Chow E, et al. Primary treatment endpoint following palliative radiotherapy for painful bone metastases: need for a consensus definition?. Clin Oncol 2002;14:70-77.
7. Chow E, Wu J, Hoskin P, et al. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiother Oncol 2002;64:275.
8. Bone Pain Trial Working Party. 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: randomised comparison with a multifraction schedule over 12 months of patient follow-up. Radiother Oncol 1999;52:111-121.
9. Steenland E, Leer JW, van Houwelingen H, et al. The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol 1999;52:101-109.
10. Roos DE, O'Brien PC, Smith JG, et al. A role for radiotherapy in neuropathic bone pain: preliminary response rates from a prospective trial (Trans-tasman radiation oncology group, TROG 96.05). Int J Radiat Oncol Biol Phys 2000;46:975-981.
11. MRC Lung Cancer Working Party. A Medical Research Council (MRC) randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status. Medical Research Council Lung Cancer Working Party. Br J Cancer 1992; 65:934-941.
12. Macbeth FR, Bolger JJ, Hopwood P, et al. Randomized trial of palliative two-fraction versus more intensive 13-fraction radiotherapy for patients with inoperable non-small cell lung cancer and good performance status. Medical Research Council Lung Cancer Working Party. Clin Oncol 1996;8:167-175.
13. Scarantino CW, Caplan R, Rotman M, et al. A phase I/II study to evaluate the effect of fractionated hemibody irradiation in the treatment of osseous metastases: RTOG 88-22. Int J Radiat Oncol Biol Phys 1996;36:37-48.
14. Salazar OM, DaMotta NW, Bridgman SM, et al. Fractionated half-body irradiation for pain palliation in widely metastatic cancers: comparison with single dose. Int J Radiat Oncol Biol Phys 1996;36:49-60.
15. Salazar OM, Sandhu T, da Motta NW, et al. Fractionated half-body irradiation (HBI) for the rapid palliation of widespread, symptomatic, metastatic bone disease: a randomized Phase III trial of the International Atomic Energy Agency (TAEA). Int J Radiat Oncol Biol Phys 2001;50:765-775.
16. Brundage MD, Crook JM, Lukka H. Use of strontium-89 in endocrine-refractory prostate cancer metastatic to bone. Provincial Genitourinary Cancer Disease Site Group. Cancer Prev Control 1998;2:79-87.
17. Sciuto R, Festa A, Pasqualoni R, et al. Metastatic bone pain palliation with 89-Sr and 186-Re-HEDP in breast cancer patients. Breast Cancer Res Treat 2001;66:101-109.
18. Resche I, Chatal JF, Pecking A, et al. A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases. Eur J Cancer 1997;33:1583-1591.